Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Chemotherapy for Relapsed Childhood ALL
NCT00002499Phase 3Unknown
- Sponsor
- Grupo Argentino de Tratamiento de la Leucemia Aguda
- Start
- Jan 1990
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of vincristine, daunorubicin, asparaginase escherichia coli, prednisone, cytarabine in acute lymphoblastic leukemia (ALL), sponsored by Grupo Argentino de Tratamiento de la Leucemia Aguda. Status: unknown.
02
Drugs
vincristinedaunorubicinasparaginase escherichia coliprednisonecytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00002499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002499.